Steroids, Body Image, and UK Drug Policy: A Contemporary Analysis
Introduction
As both an academic researcher and a coach with over a decade of experience in the strength and fitness community, I bring a dual perspective to this critical discussion on anabolic-androgenic steroids (AAS) use in the UK. My position allows me to combine theoretical insights with a practical understanding of the cultural and psychological factors influencing steroid use. Through this lens, I aim to dissect the complexities of AAS policy, its implications, and potential reforms to mitigate harm while fostering a healthier societal relationship with body image.
The prevalence of anabolic-androgenic steroids (AAS) use in the UK has seen a marked increase over the last few decades. Once considered the preserve of competitive athletes, AAS use has expanded into gyms, social circles, and communities far removed from elite sports. This rise is intricately tied to shifting societal norms, where body image and aesthetics have been commodified and idealised through social media, reality television, and the broader cultural landscape. Despite the growing societal impact of steroids, the UK’s drug policy framework remains inadequately equipped to address the unique challenges posed by this phenomenon.
This opinion piece critically examines the current state of steroid use in the UK, focusing on its socio-cultural, psychological, and criminological dimensions. By synthesising the existing literature and incorporating recent developments, this article seeks to explore the inadequacies of existing policies and propose a multifaceted approach to mitigate harm, safeguard public health, and address underlying societal issues.
The Normalisation of Steroid Use in the UK
This article serves as an indispensable resource for understanding the complex dynamics surrounding the use of anabolic-androgenic steroids (AAS), performance-enhancing drugs (PEDs), and similar substances in the UK. Key discussions include the socio-cultural drivers of use, the role of social media, the gaps in current drug policies, and potential harm-reduction strategies. For example, the significant findings from Richardson et al. (2019) highlight how gym culture and social pressures can lead individuals toward these substances, complicating the broader landscape of health and policy concerns.
A Socio-Cultural Perspective
The normalisation of AAS use can be attributed to various cultural and socio-economic factors. The rise of social media platforms such as Instagram has significantly amplified societal pressure to conform to unattainable body ideals (Griffiths et al., 2018; UK Anti-Doping, 2020). These platforms often celebrate hyper-muscular, lean physiques, which many individuals perceive as markers of success and desirability (Uchôa et al., 2019). Furthermore, the rise of selective androgen receptor modulators (SARMs) and other similar drugs has added new dimensions to the conversation about image and performance-enhancing substances.. Recent studies have revealed that this pressure is no longer confined to men; increasing numbers of women are turning to steroids to achieve the aesthetic ideals propagated by mainstream and social media (UK Anti-Doping, 2020).
Furthermore, the emergence of events like the Enhanced Games, which promote the use of performance-enhancing drugs, reflects a broader societal shift towards the acceptance of drug use in sports and fitness. These initiatives, while controversial, highlight the growing tensions between traditional anti-doping policies and the societal normalisation of enhancement (Richardson, 2024).
Economic and Psychological Dimensions
Economic disenfranchisement and a lack of social mobility in post-industrial regions of the UK also contribute to the rise in anabolic steroids use. In communities where traditional employment opportunities have diminished, an imposing physique can serve as a proxy for status and respect (Ellis, Winlow, & Hall, 2017; Antonopoulos & Hall, 2016). Moreover, the individualistic and neoliberal values that dominate modern society emphasise self-reliance and personal transformation, making steroids an attractive shortcut for those seeking validation or escape from socio-economic despair.
Psychologically, AAS use is often intertwined with low self-esteem, body image issues, and an obsessive drive to achieve a specific physical ideal. These factors are exacerbated by the perception that steroids use is a "victimless crime," with users assuming the associated health risks as personal choices (Zahnow et al., 2018). Additionally, the influence of social media and gym culture has been shown to significantly impact individuals' decisions to use image and performance-enhancing drugs (Richardson, Dixon, & Kean, 2019).
The Health and Societal Impacts of AAS Use
Physical and Mental Health Consequences
The health risks associated with AAS use are well-documented. Long-term use significantly increases the likelihood of premature death, cardiovascular diseases, liver and kidney dysfunction, and mental health disorders such as depression and aggression (Horwitz, Andersen, & Dalhoff, 2018; Filho et al., 2020). The rise of needle-related infections and complications from unsafe injection practices further exacerbates the public health burden (Aceijas & Rhodes, 2007; McVeigh & Begley, 2016).
Moreover, recent case studies have highlighted specific issues such as steroid-induced erectile dysfunction among male users, underscoring the complex health challenges associated with IPEDs consumption (Kotzé, Richardson, & Antonopoulos, 2023).
Links to Criminality and Organised Crime
Contrary to the perception of AAS use as a "harmless" pursuit, there are significant criminological implications. Organised crime groups have increasingly infiltrated the steroids market, exploiting gaps in legislation and enforcement to manufacture and distribute these substances (Fincoeur, van de Ven, & Mulrooney, 2014). Locally, informal networks of "social supply" in gyms and fitness communities blur the lines between casual sharing and commercial distribution, complicating enforcement efforts (Antonopoulos & Hall, 2016).
Limitations of Current UK Drug Policy
The UK’s approach to AAS regulation is primarily framed within the Misuse of Drugs Act 1971, which classifies steroids as Class C substances. This classification restricts possession without a prescription but focuses heavily on supply and trafficking. However, enforcement efforts remain limited, with few arrests and prosecutions relative to the scale of the issue (Met Police, 2016).
A significant gap in the policy framework is the lack of emphasis on harm reduction. Public health campaigns, such as those led by UK Anti-Doping, often rely on fear-based messaging, which has historically proven ineffective (Parker, Measham, & Aldridge, 1998). Moreover, the criminalisation of AAS possession creates barriers to healthcare access, discouraging users from seeking medical advice or harm reduction services (Kimergård & McVeigh, 2014).
Towards a Holistic Approach: Recommendations for Policy Reform
Harm Reduction Strategies
Needle and Syringe Programmes (NSPs): Expanding access to NSPs can significantly reduce the risks of bloodborne infections and injection-related complications among AAS users (Fernandes et al., 2017).
Targeted Education Campaigns: Public health initiatives should adopt evidence-based strategies that provide accurate, non-sensationalised information about the risks of AAS use. Campaigns must also address the psychological drivers of use, such as body image issues (Hornik et al., 2008).
Healthcare Integration: Training general practitioners and practice nurses to screen for AAS use and offer harm reduction advice can improve early intervention and healthcare outcomes (Brooks, Ahmad, & Easton, 2016).
Addressing Supply and Regulation
Regulated Access: The decriminalisation and regulation of AAS through licensed dispensaries could improve product quality, reduce the influence of organised crime, and facilitate harm reduction efforts (McGrew, 2015).
Stricter Import Controls: Strengthening border control measures and increasing penalties for trafficking high volumes of steroids could disrupt the supply chain and limit the availability of low-quality, dangerous products (Hall & Antonopoulos, 2016).
Tackling Societal Drivers
Mental Health Support: Expanding access to mental health services, particularly for individuals suffering from body dysmorphia and low self-esteem, is crucial in addressing the root causes of steroids use (Uchôa et al., 2019).
Social Media Regulation: Imposing stricter guidelines on advertising and influencer promotions that glamorise unattainable physiques could mitigate societal pressures on body image (UK Anti-Doping, 2020).
Community-Based Interventions: Initiatives aimed at empowering communities in economically deprived areas can provide alternative pathways to status and self-worth, reducing the allure of steroids use (Ellis, Winlow, & Hall, 2017).
Conclusion
The rise of AAS use in the UK reflects broader societal shifts, from the commodification of body image to the erosion of traditional socio-economic structures. Current policies fail to adequately address the multifaceted nature of this issue, focusing disproportionately on enforcement while neglecting harm reduction and prevention.
A comprehensive approach, combining harm reduction, regulatory reform, and socio-cultural interventions, is essential for tackling the growing public health and societal challenges posed by steroids use. By prioritising education, healthcare access, and the regulation of supply, the UK can mitigate the risks associated with AAS while addressing the broader cultural and economic factors that drive its demand.
If you found this analysis insightful, I encourage you to explore my other writings, where I delve into the intersections of strength sports, public policy, and societal trends. Together, we can engage in meaningful discussions that drive change and enhance understanding.
Bibliography
Aceijas, C., & Rhodes, T. (2007). Global estimates of prevalence of HCV infection among injecting drug users. International Journal of Drug Policy, 18(5), 352-358.
Antonopoulos, G., & Hall, A. (2016). “Gain with no pain”: Anabolic-androgenic steroids trafficking in the UK. European Journal of Criminology, 13(6), 696-713.
Brooks, J., Ahmad, I., & Easton, G. (2016). Anabolic Steroid Use. British Medical Journal, 355, i5023.
Ellis, A., Winlow, S., & Hall, S. (2017). Throughout my life I’ve had people walk all over me: Trauma in the lives of violent men. The Sociological Review, 65(4), 699-713.
Fernandes, R. M., et al. (2017). Effectiveness of needle and syringe programmes in people who inject drugs: An overview of systematic reviews. BMC Public Health, 17, 309.
Filho, S., et al. (2020). Kidney disease associated with androgenic–anabolic steroids and vitamin supplements abuse: Be aware! Nefrologia, 40(1), 26-31.
Griffiths, S., Murray, S. B., Krug, I., & McLean, S. A. (2018). The contribution of social media to body dissatisfaction, eating disorder symptoms, and anabolic steroid use among sexual minority men. Cyberpsychology, Behaviour and Social Networking, 21(3), 149-156.
Hall, S., & Winlow, S. (2015). Revitalising Criminological Theory: Towards a New Ultra-Realism. London: Routledge.
Hornik, R. C., et al. (2008). Effects of the national youth anti-drug media campaign on youths. American Journal of Public Health, 98(12), 2229-2236.
Horwitz, H., Andersen, J. T., & Dalhoff, K. P. (2018). Health consequences of androgenic anabolic steroid use. Journal of Internal Medicine, 285(3), 333-340.
Kimergård, A., & McVeigh, J. (2014). Variability and dilemmas in harm reduction for anabolic steroid users in the UK: A multi-area interview study. Harm Reduction Journal, 11(19).
Kotzé, J., Richardson, A., & Antonopoulos, G. (2023). Steroid-induced dysfunction and its social impacts. Journal of Performance Enhancing Research, 7(1), 15-30.
McVeigh, J., & Begley, E. (2016). Anabolic steroids in the UK: An increasing issue for public health. Drugs: Education, Prevention and Policy, 24(3), 278-285.
Richardson, A., Dixon, T., & Kean, J. (2019). Influences of gym culture on AAS use. Health Psychology Review, 13(4), 334-346.
Richardson, A. (2024). The Enhanced Games or Enhancing Harm? International Journal of Doping Studies, 10(1), 45-67.
UK Anti-Doping. (2020). Image and IPEDs: UKAD’s Status Report on IPEDs in the UK. London: UK Anti-Doping.
Uchôa, F. N., et al. (2019). Influence of the mass media and body dissatisfaction on the risk in adolescents of developing eating disorders. International Journal of Environmental Research and Public Health, 16(9), 1508.
Zahnow, R., McVeigh, J., Bates, G., et al. (2018). Identifying a typology of men who use anabolic androgenic AAS (steroids). International Journal of Drug Policy, 55, 105-112.
Comments